Pharmacological management of SAPHO syndrome
- 21 September 2006
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Investigational Drugs
- Vol. 15 (10) , 1229-1233
Abstract
The SAPHO (synovitis, acne, pustulosis, hyperostosis and osteitis) syndrome (SaS) includes different skeletal manifestations such as recurrent multifocal osteomyelitis, osteitis and arthritis, which are frequently associated with different forms of skin pustulosis (palmoplantar pustulosis, pustular psoriasis and severe acne). This syndrome is strictly related to the spondyloarthopathies (particularly to psoriatic arthritis) and many SaS cases fulfil the classification criteria for the spondyloarthopathies. Because SaS is an uncommon disease, current knowledge regarding its therapy is based on limited experiences gained by treating mainly small groups of patients. As a consequence, its treatment is still empiric. Several drugs (including NSAIDs, corticosteroids, sulfasalazine, methotrexate, ciclosporin, leflunomide, calcitonin and so on) have been administered and obtained conflicting results. The use of antibiotics, due to the isolation of Propionibacterium acnes from the bone biopsies of several subjects...Keywords
This publication has 35 references indexed in Scilit:
- In SAPHO syndrome anti-TNF-α therapy may induce persistent amelioration of osteoarticular complaints, but may exacerbate cutaneous manifestationsRheumatology, 2006
- Successful Treatment of Chronic Recurrent Multifocal Osteomyelitis With Tumor Necrosis Factor-α BlockagePediatrics, 2005
- Acne fulminans with synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome treated with infliximabJournal of the American Academy of Dermatology, 2005
- SAPHO syndrome and pamidronate revisitedRheumatology, 2005
- Pamidronate in the treatment of childhood SAPHO syndromeRheumatology, 2004
- Persistent efficacy of tumor necrosis factor α blockage therapy in SAPHO syndrome: Comment on the article by Wagner et alArthritis & Rheumatism, 2003
- Sustained response to tumor necrosis factor α–blocking agents in two patients with SAPHO syndromeArthritis & Rheumatism, 2002
- Pamidronate: a novel treatment for the SAPHO syndrome?Rheumatology, 2002
- Wirbelkörperdestruktionen mit massiven Schmerzen durch das SAPHO-SyndromDMW - Deutsche Medizinische Wochenschrift, 1999
- Calcitonin treatment for intersternocostoclavicular ossification: clinical experience in two cases.Annals of the Rheumatic Diseases, 1991